Author:
Brouwer B. G.,Visseren F. L. J.,Algra A.,van Bockel J. H.,Bollen E. L. E. M.,Doevendans P. A.,Greving J. P.,Kappelle L. J.,Moll F. L.,Pijl H.,Romijn J. A.,van der Wall E. E.,van der Graaf Y.
Reference38 articles.
1. Overview of atherosclerosis;Kannel;Clin Ther,1998
2. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients;BMJ,2002
3. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Cholesterol Treatment Trialists’ Collaborators;Lancet,2005
4. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators;The Heart Outcomes Prevention Evaluation Study Investigators;N Engl J Med,2000
5. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. European Action on Secondary Prevention by Intervention to Reduce Events;EUROASPIRE I and II Group;Lancet,2001
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献